RNAC · Forms 3, 4, 5
Insider trades at Cartesian Therapeutics, Inc.
No open-market insider buys or sells at Cartesian Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Cartesian Therapeutics, Inc. (RNAC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Cartesian Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Elizabeth Hoge | 10% owner | Option exercise | 758,001 | Form 4 | |||
| Murat Kalayoglu | 10% owner | Option exercise | 758,001 | Form 4 | |||
| Michael Singer | Director | Gift | 6,555 | Form 4 | |||
| Carsten Brunn | President and CEO | Sell | 23,766 | $6.82 | $162K | Form 4 | |
| Milos Miljkovic | Chief Medical Officer | Sell | 3,573 | $6.82 | $24K | Form 4 | |
| Blaine Davis | Chief Financial Officer | Sell | 10,591 | $6.82 | $72K | Form 4 | |
| Nishan M DeSilva | Director | Award | 2,600 | Form 4 | |||
| Carsten Brunn | President and CEO | Award | 143,200 | Form 4 | |||
| Kemal Malik | Director | Award | 2,600 | Form 4 | |||
| Milos Miljkovic | Chief Medical Officer | Award | 27,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.